Skip to main content

GUAIFENESIN AND DEXTROMETHORPHAN HBR

NDC 76162-032 · TOPCO ASSOCIATES LLC

Generic nameGUAIFENESIN AND DEXTROMETHORPHAN HBR
Dosage formTABLET, EXTENDED RELEASE
RouteORAL
Active ingredient(s)GUAIFENESIN, DEXTROMETHORPHAN HYDROBROMIDE
Strength60; 1200 mg/1; mg/1
Pharmacologic classDecreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA]
Marketing categoryANDA

Packages

76162-032-56 — 8 BLISTER PACK in 1 CARTON (76162-032-56) / 7 TABLET, EXTENDED RELEASE in 1 BLISTER PACK

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

73598-1342 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, and phenylephrine hydrochloride, 73629-005 — DEXTROMETHORPHAN HBR 15 MG, 75907-207 — Brompheniramine Maleate, Pseudoephedrine Hydrochloride, and Dextromethorphan Hydrobromide, 76095-012 — Guaifensin, Dextromethorphan, 76117-001 — CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PHENYLEPHRINE HYDROCHLORIDE, 76162-000 — Acetaminophen, Dextromethorphan Hydrobromide, Guaifenesin, Phenylephrine Hydrochloride, 76162-004 — Guaifenesin 400mg, 76162-008 — Mucus Relief DM, 76162-026 — Nite Time Cold and Flu Relief, 76162-031 — Guaifenesin, 76162-040 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 76162-050 — Acetaminophen, Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 76162-057 — Dextromethorphan HBr, Guaifenesin, Phenylephrine HCl, 76162-065 — Daytime Cold and Flu Relief, 76162-099 — brompheniramine maleate, dextromethorphan hydrobromide, 76162-123 — guaifenesin, 76162-198 — acetaminophen, dextromethorphan hydrobromide, guaifenesin, 76162-202 — acetaminophen, dextromethorphan hydrobromide, doxylamine succinate, phenylephrine hydrochloride, 76162-294 — Dextromethorphan HBr, Guaifensin, 76162-409 — guaifenesin, +2508 more

From the FDA National Drug Code Directory, retrieved August 24, 2026. Product listings are submitted by labelers; FDA does not verify them.